Tecan Genomics Competitors and Similar CompaniesClear all

Tecan Genomics's competitors and similar companies include Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Ginkgo Bioworks Holdings, Poseida Therapeutics and Select Sires.

	Tecan Genomics Tecan Genomics (formerly known as NuGEN Technologies) is a provider of Next Generation Sequencing (NGS) and genomic sample prep products for DNA and RNA analysis.	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.	Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.	Poseida Therapeutics Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.	Select Sires Select Sires is a company developing and delivering genetic solutions.
Founding Date	Founding Date 2000	Founding Date 1996	Founding Date 2020	Founding Date 2015	Founding Date 1965
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Technology biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Leek, NL HQ	Locations CN HQ	Locations Boston, US HQ	Locations San Diego, US HQ	Locations Plain City, US HQ
Employees	Employees 784% increase	Employees 921	Employees 1,2186% decrease	Employees 3111% decrease	Employees 332
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $170.2m (FY, 2025)	Revenue (est.) $64.7m (FY, 2023)	Revenue (est.) N/A
Net income	Net income N/A	Net income N/A	Net income ($312.8m) (FY, 2025)	Net income ($123.4m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised $ 31.5m	Total funding raised N/A	Total funding raised $ 789.1m	Total funding raised $ 336.5m	Total funding raised N/A